The rare disease diagnostics market is booming, projected to reach $3.05B by 2033, driven by advancements in NGS, WGS, and PCR testing. Learn about market trends, key players (Quest Diagnostics, Invitae, Beijing Genomics Institute), and regional growth in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.